178 related articles for article (PubMed ID: 14742907)
1. First evidence for helical transitions in supercoiled DNA by amyloid Beta Peptide (1-42) and aluminum: a new insight in understanding Alzheimer's disease.
Hegde ML; Anitha S; Latha KS; Mustak MS; Stein R; Ravid R; Rao KS
J Mol Neurosci; 2004; 22(1-2):19-31. PubMed ID: 14742907
[TBL] [Abstract][Full Text] [Related]
2. Alteration of superhelical state of DNA by aluminium (Al).
Rao KS; Rao BS; Vishnuvardhan D; Prasad KV
Biochim Biophys Acta; 1993 Feb; 1172(1-2):17-20. PubMed ID: 8439556
[TBL] [Abstract][Full Text] [Related]
3. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of the DNA nicking property of amyloid-β40: implications in Alzheimer's disease.
Gupta VB; Monica FS; Berrocal R; Rao KS; Rao KS
J Alzheimers Dis; 2013; 33(4):1059-71. PubMed ID: 23160010
[TBL] [Abstract][Full Text] [Related]
5. Aluminium Binding to Modified Amyloid-β Peptides: Implications for Alzheimer's Disease.
Mocanu CS; Jureschi M; Drochioiu G
Molecules; 2020 Oct; 25(19):. PubMed ID: 33022965
[TBL] [Abstract][Full Text] [Related]
6. A new evidence for DNA nicking property of amyloid beta-peptide (1-42): relevance to Alzheimer's disease.
Suram A; Hegde ML; Rao KS
Arch Biochem Biophys; 2007 Jul; 463(2):245-52. PubMed ID: 17502108
[TBL] [Abstract][Full Text] [Related]
7. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
Butterfield DA
Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of curcumin on the Al(III)-induced Aβ₄₂ aggregation and neurotoxicity in vitro.
Jiang T; Zhi XL; Zhang YH; Pan LF; Zhou P
Biochim Biophys Acta; 2012 Aug; 1822(8):1207-15. PubMed ID: 22561904
[TBL] [Abstract][Full Text] [Related]
9. Conformations and biological activities of amyloid beta peptide 25-35.
Millucci L; Ghezzi L; Bernardini G; Santucci A
Curr Protein Pept Sci; 2010 Feb; 11(1):54-67. PubMed ID: 20201807
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail.
Chang YJ; Linh NH; Shih YH; Yu HM; Li MS; Chen YR
ACS Chem Neurosci; 2016 Aug; 7(8):1097-106. PubMed ID: 27227450
[TBL] [Abstract][Full Text] [Related]
11. Structure inducing ionic liquids-enhancement of alpha helicity in the Abeta(1-40) peptide from Alzheimer's disease.
Debeljuh N; Barrow CJ; Henderson L; Byrne N
Chem Commun (Camb); 2011 Jun; 47(22):6371-3. PubMed ID: 21547327
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor.
Xie L; Helmerhorst E; Taddei K; Plewright B; Van Bronswijk W; Martins R
J Neurosci; 2002 May; 22(10):RC221. PubMed ID: 12006603
[TBL] [Abstract][Full Text] [Related]
14. Molecular details of aluminium-amyloid β peptide interaction by nuclear magnetic resonance.
Petersingham G; Zaman MS; Johnson AJ; Reddy N; Torres AM; Wu MJ
Biometals; 2022 Aug; 35(4):759-769. PubMed ID: 35639270
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
16. First evidence on induced topological changes in supercoiled DNA by an aluminium D-aspartate complex.
Bharathi ; Jagannatha Rao KS; Stein R
J Biol Inorg Chem; 2003 Nov; 8(8):823-30. PubMed ID: 14517616
[TBL] [Abstract][Full Text] [Related]
17. Microarray analysis on human neuroblastoma cells exposed to aluminum, β(1-42)-amyloid or the β(1-42)-amyloid aluminum complex.
Gatta V; Drago D; Fincati K; Valenti MT; Dalle Carbonare L; Sensi SL; Zatta P
PLoS One; 2011 Jan; 6(1):e15965. PubMed ID: 21298039
[TBL] [Abstract][Full Text] [Related]
18. Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation.
Miles LA; Crespi GA; Doughty L; Parker MW
Sci Rep; 2013; 3():1302. PubMed ID: 23416764
[TBL] [Abstract][Full Text] [Related]
19. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.
Kawarabayashi T; Shoji M; Younkin LH; Wen-Lang L; Dickson DW; Murakami T; Matsubara E; Abe K; Ashe KH; Younkin SG
J Neurosci; 2004 Apr; 24(15):3801-9. PubMed ID: 15084661
[TBL] [Abstract][Full Text] [Related]
20. Identification of peptides that specifically bind Abeta1-40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display.
Kang CK; Jayasinha V; Martin PT
Neurobiol Dis; 2003 Oct; 14(1):146-56. PubMed ID: 13678675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
